1. Home
  2. ELTX vs AFMD Comparison

ELTX vs AFMD Comparison

Compare ELTX & AFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • AFMD
  • Stock Information
  • Founded
  • ELTX 2011
  • AFMD 2000
  • Country
  • ELTX United States
  • AFMD Germany
  • Employees
  • ELTX N/A
  • AFMD N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • AFMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELTX Health Care
  • AFMD Health Care
  • Exchange
  • ELTX Nasdaq
  • AFMD Nasdaq
  • Market Cap
  • ELTX 49.7M
  • AFMD 53.3M
  • IPO Year
  • ELTX 2021
  • AFMD 2014
  • Fundamental
  • Price
  • ELTX $4.16
  • AFMD $3.36
  • Analyst Decision
  • ELTX Buy
  • AFMD Strong Buy
  • Analyst Count
  • ELTX 2
  • AFMD 5
  • Target Price
  • ELTX $10.00
  • AFMD $16.25
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • AFMD 80.0K
  • Earning Date
  • ELTX 11-07-2024
  • AFMD 11-12-2024
  • Dividend Yield
  • ELTX N/A
  • AFMD N/A
  • EPS Growth
  • ELTX N/A
  • AFMD N/A
  • EPS
  • ELTX N/A
  • AFMD N/A
  • Revenue
  • ELTX N/A
  • AFMD $7,959,927.00
  • Revenue This Year
  • ELTX N/A
  • AFMD N/A
  • Revenue Next Year
  • ELTX N/A
  • AFMD $48.98
  • P/E Ratio
  • ELTX N/A
  • AFMD N/A
  • Revenue Growth
  • ELTX N/A
  • AFMD N/A
  • 52 Week Low
  • ELTX $2.96
  • AFMD $2.92
  • 52 Week High
  • ELTX $11.45
  • AFMD $8.95
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • AFMD 44.84
  • Support Level
  • ELTX $4.05
  • AFMD $3.28
  • Resistance Level
  • ELTX $4.89
  • AFMD $3.51
  • Average True Range (ATR)
  • ELTX 0.28
  • AFMD 0.17
  • MACD
  • ELTX -0.06
  • AFMD 0.04
  • Stochastic Oscillator
  • ELTX 27.37
  • AFMD 55.79

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

Share on Social Networks: